Neurovascular dysfunction in diabetic retinopathy: mechanisms and therapeutic perspectives
Frontiers in Endocrinology · 12.11.2026 · 17
DOI: 10.3389/fendo.2026.2003705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 12.11.2026. Verfasst von Xi Hu und 5 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Diabetic retinopathy (DR) involves dysfunction of the retinal neurovascular unit (NVU) in addition to clinically detectable microvascular lesions. This narrative review critically examines how metabolic and organelle stress, neuroglial inflammation, and blood–retinal barrier dysfunction contribute to impaired retinal homeostasis. We propose an evidence-to-decision framework that distinguishes candidate initiating mechanisms, disease amplifiers, persistence programs, and potential treatment-escape pathways according to the strength of causal evidence and clinical relevance. Findings from human studies, experimental models, and clinical trials are evaluated separately to avoid conflating molecular associations with established mechanisms of disease progression. Particular attention is given to the distinction between clinical metabolic memory and experimentally demonstrated molecular persistence, as well as between alternative angiogenic signaling and clinically validated resistance to vascular endothelial growth factor inhibition. Emerging imaging, electrophysiological, and molecular biomarkers may help characterize neurovascular heterogeneity, but their prognostic and predictive value remains insufficiently established. We identify key experimental and clinical studies needed to validate mechanistic hypotheses, clarify their relationship to functional outcomes, and assess their therapeutic relevance. This synthesis provides a framework for prioritizing testable mechanisms while emphasizing that mechanism-guided patient stratification and treatment selection require prospective clinical validation.
Zitieren
APA
Hu, X., Gu, C., Liu, Y., Cao, Y., Wang, J., & Yao, J. (2026). Neurovascular dysfunction in diabetic retinopathy: mechanisms and therapeutic perspectives. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.2003705
Vancouver
Hu X, Gu C, Liu Y, Cao Y, Wang J, Yao J. Neurovascular dysfunction in diabetic retinopathy: mechanisms and therapeutic perspectives. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.2003705
BibTeX
@article{Hu2026,
author = {Hu, Xi and Gu, Chenhao and Liu, Ying and Cao, Yuqi and Wang, Jiadi and Yao, Jing},
title = {Neurovascular dysfunction in diabetic retinopathy: mechanisms and therapeutic perspectives},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.2003705}
}
EUVIMED